Tci Wealth Advisors, Inc. Exact Sciences Corp Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$47.19 - $70.77 $21,896 - $32,837	464 Added 15466.67%	467 $31,000
Q4 2022 Feb 06, 2023	SELL	$30.35 - $53.15 $9,135 - $15,998	-301 Reduced 99.01%	3 $0
Q3 2022 Nov 08, 2022	BUY	$31.97 - $49.37 $63 - $98	2 Added 0.66%	304 $10,000
Q2 2022 Jul 19, 2022	BUY	$35.61 - $76.23 $9,009 - $19,286	253 Added 516.33%	302 $12,000
Q4 2021 Jan 24, 2022	SELL	$72.5 - $100.68 $3,842 - $5,336	-53 Reduced 51.96%	49 $4,000
Q3 2021 Oct 29, 2021	BUY	$90.24 - $124.05 $1,714 - $2,356	19 Added 22.89%	102 $10,000
Q2 2021 Aug 02, 2021	BUY	$93.66 - $139.27 $1,498 - $2,228	16 Added 23.88%	83 $10,000
Q1 2021 Apr 29, 2021	BUY	$116.57 - $155.01 $2,098 - $2,790	18 Added 36.73%	67 $9,000
Q3 2020 Oct 20, 2020	SELL	$72.92 - $102.01 $218 - $306	-3 Reduced 5.77%	49 $5,000
Q2 2020 Jul 20, 2020	SELL	$55.75 - $92.75 $892 - $1,484	-16 Reduced 23.53%	52 $5,000
Q2 2017 Aug 10, 2017	BUY	N/A	68	68 $2,000

667

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.91B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.